Atossa Therapeutics
ATOS
#10053
Rank
ยฃ30.12 M
Marketcap
ยฃ3.50
Share price
-1.88%
Change (1 day)
376.93%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -ยฃ22.86 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ19.03 Million, an increase over its 2023 earnings that were of -ยฃ22.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ22.86 Million20.15%
2024 -ยฃ19.03 Million-15.25%
2023 -ยฃ22.45 Million11.62%
2022 -ยฃ20.12 Million30.84%
2021 -ยฃ15.38 Million15.58%
2020 -ยฃ13.3 Million3.41%
2019 -ยฃ12.86 Million51.16%
2018 -ยฃ8.51 Million40.41%
2017 -ยฃ6.06 Million27.54%
2016 -ยฃ4.76 Million-47.49%
2015 -ยฃ9.05 Million-17.25%
2014 -ยฃ10.94 Million35.91%
2013 -ยฃ8.05 Million112.3%
2012 -ยฃ3.79 Million46.53%
2011 -ยฃ2.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.37 B-86,180.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.02 B-4,659.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ1.02 B-4,656.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ31.09 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-ยฃ74.19 Million 229.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-ยฃ5.85 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA